Patent · US Active

Compounds as respiratory stimulants for treatment of breathing control disorders or diseases

US9351972B2 · kind B2 · utility

3Cited by
6References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2011
Grant dateMay 31, 2016
Priority date
Expiry dateNov 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes a composition comprising a compound, such as a 2,4,6-triamino-1,3,5-triazine, 2,4,6-triaminopyrimidine, 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine or 2,4-diamino-7H-pyrrolo[2,3-d]pyrimidine, that is useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention. The present invention further includes a method of preventing destabilizing or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.